Key result
Liver re-transplantation normalizes severe lipoprotein X-mediated hypercholesterolemia within 4 months in chronic cholestasis.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Case report shows normalization of severe lipoprotein X-mediated hypercholesterolemia following liver re-transplantation in chronic cholestasis, highlighting definitive surgical resolution.
Hypercholesterolemia is a common disorder in adult population, but total cholesterol concentrations beyond 1000 mg/dl occur rarely, and are found in patients with homozygous familial hypercholesterolemia and familial lecithin-cholesterol acyltransferase deficiency, in chronic graft-versus-host disease of the liver, after intravenous infusion of fat emulsion (intralipid), in newborn infants with immature liver function, and in obstructive biliary cholestasis. Cholestasis induces a dramatic increase in plasma cholesterol and the appearance of an abnormal lipoprotein, lipoprotein X (LpX), in the plasma. We report a case of severe hypercholesterolemia mediated by LpX in a patient transplanted for primary biliary cirrhosis (PBC), who was qualified for liver re-transplantation (re-LTx) due to chronic cholestasis. Four months after re-LTx, the cholesterol concentration was normal. The problems in diagnosis and treatment are discussed.
No takes yet. Share an insight, caveat, or question.
Jankowski et al. (2015) conducted a case report in Severe hypercholesterolemia mediated by lipoprotein X and chronic cholestasis after liver transplantation for primary biliary cirrhosis (n=1). Liver re-transplantation (re-LTx) was evaluated on Normalization of plasma cholesterol concentration. Liver re-transplantation normalized severe lipoprotein X-mediated hypercholesterolemia within 4 months in a patient with chronic cholestasis.
Synapse has enriched 10 related papers. Consider them for comparative context: